Successful kidney transplant with eculizumab, thymoglobulin and belatacept therapy in a highly sensitised patient with atypical haemolytic uraemic syndrome due to factor H mutation

Atypical haemolytic uraemic syndrome is a disease caused by complement regulation abnormalities that generally progresses to chronic end-stage renal disease with a high rate of recurrence in kidney transplantation and a high risk of graft loss. Anti-complement therapy has improved the prognosis of t...

Full description

Bibliographic Details
Main Authors: John Fredy Nieto-Ríos, Mónica Zuluaga-Quintero, Diana Carolina Bello-Márquez, Arbey Aristizabal-Alzate, Catalina Ocampo-Kohn, Lina María Serna-Higuita, Lina Arias, Gustavo Zuluaga-Valencia
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Nefrología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S201325141830066X